GPR100, also known as RXFP4, is a fascinating member of the rhodopsin family of G protein-coupled receptors (GPCRs). This protein plays a significant role in cellular communication, functioning as a receptor for specific ligands to elicit a cascade of intracellular events. The intricacies of GPR100's regulatory mechanisms remain a robust area of scientific inquiry, with ongoing research aimed at unraveling the molecular intricacies that govern its expression. GPR100's physiological roles are as varied as the stimuli that modulate its activity, underscored by its widespread expression in human tissues and its evolutionary conservation across species. The gene's lineage traces back through eukaryotic organisms, indicating its long-standing contribution to biological systems. Known by several aliases including GPCR142 and RLN3R2, GPR100's diverse nomenclature reflects its multifaceted nature and the breadth of research interest it has garnered over the years.
The quest to identify chemical activators that can selectively induce the expression of GPR100 is driven by a deep interest in the fundamental aspects of cellular regulation and signal transduction. Compounds such as forskolin, known for its ability to raise intracellular cAMP levels, can act as a catalyst, potentially initiating a signaling cascade that culminates in the upregulation of GPR100. Similarly, isoproterenol, by engaging beta-adrenergic receptors, could spark a rise in cAMP that, in turn, may promote the gene's expression. Retinoic acid, through its interaction with nuclear receptors, also stands as a candidate capable of influencing the transcriptional machinery towards the expression of GPR100. Beyond these, agents like phorbol esters, which activate protein kinase C, and PPAR-gamma agonists such as rosiglitazone, could play a role in the transcriptional activation of GPR100. The exploration of these activators offers a window into the dynamic regulatory environment of GPCRs, shedding light on the complex interplay between extracellular signals and gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, resulting in an upsurge in cyclic AMP (cAMP) levels, which may initiate a cascade leading to the transcriptional activation of RXFP4/GPR100. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol triggers beta-adrenergic receptors, causing a surge in intracellular cAMP. Elevated cAMP may act as a secondary messenger to induce the expression of RXFP4/GPR100. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to its nuclear receptors, which then bind to retinoic acid response elements in DNA, leading to a potential increase in RXFP4/GPR100 gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit glycogen synthase kinase-3, fostering an environment that may stimulate the transcription factors involved in the upregulation of RXFP4/GPR100. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C, which may trigger a signaling pathway that culminates in the increased transcription of the RXFP4/GPR100 gene. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Rosiglitazone engages PPAR-gamma, which may bind to PPAR response elements, possibly stimulating an upturn in RXFP4/GPR100 transcription. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Cholesterol can alter membrane fluidity and potentially create a cellular environment that enhances the assembly of transcriptional machinery at the RXFP4/GPR100 gene locus. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol interacts with estrogen receptors, which may bind to estrogen response elements and initiate a transcriptional response that includes the upregulation of RXFP4/GPR100. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone engages with glucocorticoid receptors, which may initiate transcriptional events leading to the upsurge in RXFP4/GPR100 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate, a histone deacetylase inhibitor, can lead to the unwinding of DNA from histones, potentially exposing the RXFP4/GPR100 promoter region to transcriptional activators. |